Owlstone Medical’s breath biopsy test improves detection of liver disease
Study detected Nonalcoholic Fatty Liver Disease and Nonalcoholic steatohepatitis
Read More
Tag: Owlstone Medical
Owlstone Medical explores breath-based testing for more diseases
The company will use ‘Exogenous Volatile Organic Compound Probes’.
Read More
Owlstone, Imperial College London link on asthma study
UK diagnostics group Owlstone Medical has formed a pact with Imperial College London allowing use of its breath analysis technology in a study assessing the underlying causes of exacerbations in severe asthma patients.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
